Diego Sacristan is Senior Vice President, Pfizer’s Oncology US Lead, and a member of the Global Oncology Leadership Team.
In this role, Diego leads an industry-leading portfolio of more than 20 approved innovative cancer medicines and biosimilars across more than 30 indications in the US, with a focus on breast cancer, genitourinary cancer, hematology, and precision medicine.
Prior to this role, Diego served as Regional President for International Developed Markets (Europe, Japan, Korea, Australia/NZ, Russia, Turkey, and Israel). Diego started his career with Pfizer in Spain and has been with the company for 18 years in a number of roles spanning a broad set of responsibilities across Europe, Latin America, Africa, Middle East, and Asia.
Diego leads Pfizer’s Latino Colleague Council, a group that provides networking, leadership training, and mentoring programs, as well as opportunities to celebrate the ethnic and cultural diversity of Pfizer’s Latino community.
Diego received both a bachelor’s and master’s degree in Economics and Management from the Universidad Complutense in Madrid. He also completed the Advance Management Program (PDD) from IESE Business School.